West Pharmaceutical Services has broken ground on its new pharmaceutical component manufacturing facility in Waterford, Ireland, to meet increasing customer demand.

Expected to become operational in late 2018, the facility will employ close to 150 people in engineering, production and other roles.

Go deeper with GlobalData

Premium Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

The 95,000ft² facility will manufacture packaging components for insulin injector cartridges and other high-value packaging components for injectable drugs.

"West’s presence in Ireland is of great importance to us for meeting customer demand for high-quality packaging components."

It will also be capable of manufacturing additional proprietary injectable component product lines such as Westar RU and NovaPure for packaging injectable medicines.

West Pharmaceutical Services CEO Eric Green said: "West’s presence in Ireland is of great importance to us for meeting customer demand for high-quality packaging components.

See Also:

"Packaging systems play an important role in ensuring the purity, long-term stability and efficacy of injectable drug products. The advanced components that will be produced at our state-of-the-art Waterford plant will help our pharmaceutical and biotechnology customers deliver their products to patients."

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

The new facility will also function as a center of excellence for West’s proprietary elastomeric sheeting, which is used to package insulin for use in pen injectors.

West recently completed a multimillion Euro expansion at its manufacturing and development centre in Dublin.

West’s global contract manufacturing solutions provider Tech Group Europe operates from the Dublin centre, offering device design, development and manufacturing services for pharmaceutical, biotechnology and medical device manufacturers.